Cerus Corporation (CERS) Financials

CERS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 205.2 million 134.5 million
March 31, 2026 222.9 million 154.6 million
Dec. 31, 2025 221.9 million 156.9 million
Sept. 30, 2025 215.2 million 153.0 million

CERS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.5 million 5.5 million
March 31, 2026 -3.3 million 4.9 million
Dec. 31, 2025 4.9 million 10.6 million
Sept. 30, 2025 94000 5.6 million

CERS Net Income

No data available :(

CERS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 56.3 million 34.8 million 11.9 million
March 31, 2026 80.4 million 32.4 million 12.5 million
Dec. 31, 2025 82.9 million 40.5 million 13.1 million
Sept. 30, 2025 78.5 million 48.7 million 13.3 million

CERS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 200.6 million
March 31, 2026 194.1 million
Dec. 31, 2025 192.1 million
Sept. 30, 2025 191.8 million

CERS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 873000 14.4 million 22.9 million -
March 31, 2026 233000 14.5 million 19.9 million -
Dec. 31, 2025 1.3 million 16.4 million 20.8 million -
Sept. 30, 2025 1.8 million 15.8 million 18.6 million -

CERS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 57.4 million 27.9 million
March 31, 2026 53.7 million 25.8 million
Dec. 31, 2025 57.8 million 28.0 million
Sept. 30, 2025 52.7 million 24.6 million

CERS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CERS

Price: $2.28

52 week price:
1.38
3.47

Earnings Per Share: -0.03 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 1.8 million

Ebitda: -11.8 million

Market Capitalization: 471.6 million

Links: